UNSPSC 51202303: Penicillamine

This classification denotes an angiogenesis activator inhibitor with the molecular formula C5H11NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) GNN1DV99GX, chemically known as valine, 3-mercapto-, l- but more generally known as penicillamine, which bears US NIH Compound Identifier 4727. European Medicines Agency schedules Penicillamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09667MIG. The term PENICILLAMINE is an International Non-Proprietary Name.

UNSPSC 51202303 Penicillamine is a Commodity code that maps poorly to the recent state and local solicitations posted under it. The code nominally describes a specific pharmaceutical ingredient, but the recent opportunities show state and local governments buying broader pharmaceutical procurement and distribution services—naloxone and drug deactivation systems, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, and direct-to-manufacturer prescription programs—rather than penicillamine specifically. Issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, serving Minnesota and Oregon). The mismatch between the code's nominal scope and actual procurement activity suggests this code sees limited relevant recent activity for vendors specializing in penicillamine or narrow-spectrum pharmaceutical ingredients.

Recent opportunities in this space include Seminole County's competitive bid (IFB60459723LAS, due July 26, 2023) for naloxone and drug deactivation systems with quarterly deliveries to the county community health building; the Texas Health and Human Services Commission's Request for Information (HHS0017013, posted April 3, 2026) to explore direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels; and MMCAP's Request for Proposal (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers to participating state and local government facilities. Geographic activity clusters in Florida, Texas, and the upper Midwest (Minnesota and Oregon through MMCAP), though the code itself shows limited direct alignment with penicillamine procurement.